Get a Call

Market News

  • 11


    Take Solutions update on proposed acquisitions of US based entities

    Take Solutions update on two proposed acquisition as under -

    Target entity 1 - KAI Research (KAI is a US based niche Full service CROand health research company)

    Objective - With this acquisition, TAKE acquires Phase II and Ill capabilities in North America adding to its current service offerings in Europe & Asia. The company has some differentiated offerings by way of patient registries and e-clinical solutions KAI strengthens our therapeutic expertise mental health, musculoskeletal diseases, CNS, infectious diseases, Oncology and medical devices. The target has long-standing relationships with clinical sites and trusted network of service providers.

    The acquisition is expected to close by January 2019, subject to customaryclosing conditions.

    The total consideration for transaction shall be up to USD 27 million, including contingent payments subject to certain financial milestones.

    Target entity 2 - DataCeutics (DataCeutics is a specialty Clinical Functional Service Provider based in the USA, headquartered in Philadelphia, USA)

    Objective - This acquisition strengthens TAKE`s domain strength in Data Sciences specific to Life Sciences enabling it to partner with the company`s clients providing much higher value adds in their Go-ToMarket strategy in terms of time, technology, and ease of change management to pharma & biotech companies that need to embrace emerging data sources that need a higher level of digital maturity.

    The acquisition is expected to close by February 2019, subject to customary closing conditions.

    The total consideration for this transaction shall be up to USO 45 million, including contingent payments subject to certain financial milestones.

    Powered by Capital Market - Live News

NIFTY 10829.35 img 88.00

SENSEX 36701.16 img 228.23

GOLD 37599.00

SILVER 43708.00

1 USD / INR 71.67

Attention Investors! "Prevent Unauthorised Transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of Investors."           Attention Investors! "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL/CDSL on the same day. Issued in the interest of investors."           "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."           "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."           "As per SEBI guidelines, old DIS cannot be accepted for execution of instruction with effect from 07-01-2016. Kindly submit requisition slip / letter for issuance of new DIS booklet at our corporate office address to avoid rejection of your instruction(s) on or after 07-01-2016.”            "In accordance with the Union Budget 2017-18 announcement, SEBI has advised to link Aadhar with individual demat accounts. Kindly submit details of Aadhar number along with copy of Aadhar Card.”          

Copyright © 2019. All Rights Reserved. Indiabulls Ventures Limited. | Cookie Policy | Bechmark Rates | Disclaimer | Terms and Condition | Blog

Indiabulls Ventures Limited. [Corporate Identification Number for IVL: L74999DL1995PLC069631]
SEBI Reg No: INZ000007534 | NSE Membership No: 08756 [CM, FNO, CDS] | BSE Membership No: 907 [CM, FNO]
Indiabulls Securities Limited (Formerly known as Indiabulls Commodities Limited) [Corporate Identification Number for ISL: U74999DL2003PLC122874]
SEBI Reg No: INZ000036136 | MCX: MEMBER CODE: 12835 | NCDEX: MEMBER CODE: 10
Registered office address: M - 62 & 63, First Floor, Connaught Place, New Delhi - 110001.
Correspondence office address: Indiabulls House, 448 – 451, Udyog Vihar, Phase – V, Gurgaon – 122016, Haryana.
Site best viewed in IExplorer 10+ | Chrome | Firefox